CAS 916979-34-5

3,6-dideuterio-1,7-dihydropyrazolo[3,4-d]pyrimidin-4-one

Description:

3,6-Dideuterio-1,7-dihydropyrazolo[3,4-d]pyrimidin-4-one is a deuterated derivative of a pyrazolopyrimidine compound, characterized by the presence of deuterium atoms at the 3 and 6 positions of the pyrazolo ring. This modification can influence the compound's physical and chemical properties, such as its stability, reactivity, and isotopic labeling, which is often utilized in research and pharmaceutical applications. The compound features a fused bicyclic structure, which contributes to its potential biological activity. It may exhibit properties typical of pyrazolo[3,4-d]pyrimidines, including interactions with various biological targets, making it of interest in medicinal chemistry. The presence of deuterium can also enhance the compound's metabolic stability and alter its pharmacokinetics. As with many heterocyclic compounds, its solubility, melting point, and spectral characteristics (such as NMR and mass spectrometry) would be essential for its identification and characterization in laboratory settings. Overall, this compound represents a valuable tool in the study of drug design and development.

Formula: C₅H₂D₂N₄O

InChI: InChI=1/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)/i1D,2D

SMILES: c1(c2c(nc(nc2O)[2H])n[nH]1)[2H]

Allopurinol-d2

CAS: 916979-34-5

Formula: C₅H₂D₂N₄O

Color and Shape: Off-White Solid

Molecular weight: 138.13

Ref: 4Z-A-692

Allopurinol-d2

Controlled Product

CAS: 916979-34-5

Applications Labelled xanthine oxidase inhibitor; decreases uric acid production. Used in treatment of hyperuricemia and chronic gout. Antiurolithic.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Benezra, S.A., et al.: Anal. Profiles Drug Subs., 7, 1, (1978), Dalbeth, N., et al.: Rheumatology, 44, 1090 (2005), Dinarello, C., et al.: J. Exp. Med., 201, 1355 (2005),

Formula: C₅₂H₂H₂N₄O

Color and Shape: Light Brown

Molecular weight: 138.12

Ref: TR-A547302

Allopurinol-d2

CAS: 916979-34-5

Allopurinol-d2 is an inhibitor of xanthine oxidase, which is an enzyme that catalyzes the conversion of hypoxanthine to xanthine and then to uric acid. Allopurinol-d2 is used for the treatment of gout and hyperuricemia. The compound was expressed in Escherichia coli and purified by electrospray ionization mass spectrometry. It has been shown to inhibit methyltransferase activity, thereby decreasing the production of urate. Allopurinol-d2 has also been shown to decrease disease activity in animal models of colitis and ulcerative colitis.

Formula: C₅H₂D₂N₄O

Purity: Min. 95%

Molecular weight: 138.12 g/mol

Ref: 3D-FA162226

Allopurinol-d2

CAS: 916979-34-5

Formula: C₅H₂D₂N₄O

Color and Shape: Solid

Molecular weight: 138.1238

Ref: IN-DA003NPE